Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

TI Verhoef; Ken Redekop; F Hasrat; A de Boer; AH Maitland-van der Zee

doi:10.1007/s40256-014-0092-1

Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

TI Verhoef, Ken Redekop, F Hasrat, A de Boer, AH Maitland-van der Zee

Research output: Contribution to journal › Article › Academic

33 Citations (Scopus)

Original language	English
Pages (from-to)	451-462
Number of pages	11
Journal	American Journal of Cardiovascular Drugs
Volume	14
Issue number	6
DOIs	https://doi.org/10.1007/s40256-014-0092-1
Publication status	Published - 2014
Externally published	Yes

Access to Document

10.1007/s40256-014-0092-1

REPUB_87887-OA.pdfFinal published version, 1.01 MB

Cite this

@article{a78495575d164d419f9f90cc26071148,

title = "Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings",

author = "TI Verhoef and Ken Redekop and F Hasrat and {de Boer}, A and {Maitland-van der Zee}, AH",

year = "2014",

doi = "10.1007/s40256-014-0092-1",

language = "English",

volume = "14",

pages = "451--462",

journal = "American Journal of Cardiovascular Drugs",

issn = "1175-3277",

publisher = "Adis International Ltd",

number = "6",

}

Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings. / Verhoef, TI; Redekop, Ken; Hasrat, F; de Boer, A; Maitland-van der Zee, AH.

In: American Journal of Cardiovascular Drugs, Vol. 14, No. 6, 2014, p. 451-462.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

AU - Verhoef, TI

AU - Redekop, Ken

AU - Hasrat, F

AU - de Boer, A

AU - Maitland-van der Zee, AH

PY - 2014

Y1 - 2014

U2 - 10.1007/s40256-014-0092-1

DO - 10.1007/s40256-014-0092-1

M3 - Article

VL - 14

SP - 451

EP - 462

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

SN - 1175-3277

IS - 6

ER -